What is your approach to first-line treatment of light chain deposition disease?

Do you treat similar to Amyloid, e.g. with Dara-CyBor-D

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Do you continue daratumumab beyond 24 months in first line treatment of amyloidosis?

In your practice, what premedications do you use for subcutaneous daratumumab?

While using bridging therapy prior to CAR-T cells in myeloma, if possible, do you target a certain response prior to proceeding with cell infusion?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.